COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 966: Articles 9651-9660  | Next

Distinct genetic determinants and mechanisms of SARS-CoV-2 resistance to remdesivir
Stevens, L. J., Pruijssers, A. J., Lee, H. W., Gordon, C. J., Tchesnokov, E. P., Gribble, J., George, A. S., Hughes, T. M., Lu, X., Li, J., Perry, J. K., Porter, D. P., Cihlar, T., Sheahan, T. P., Baric, R. S., Gotte, M., Denison, M. R.
10.1101/2022.01.25.477724 — Posted: 2022-01-29
Wastewater surveillance for COVID-19 response at multiple geographic scales: Aligning wastewater and clinical results at the census-block level and addressing pervasiveness of qPCR non-detects
Safford, H., Zuniga-Montanez, R. E., Kim, M., Wu, X., Wei, L., Sharpnack, J., Shapiro, K., Bischel, H.
10.1101/2022.01.28.22269911 — Posted: 2022-01-29
Psychological Outcomes of Surgery Trainees in the Era of COVID-19 at a Tertiary Care Hospital of Karachi, Pakistan: A Cross-Sectional Study
Lakhani, G., Bajwa, M. H., Zahid, N., Enam, S. A.
10.1101/2022.01.27.22269982 — Posted: 2022-01-29
Continuing inequalities in COVID-19 mortality in England and Wales, and the changing importance of regional, over local, deprivation
Griffith, G. J., Owen, G., Manley, D., Howe, L. D., Davey Smith, G.
10.1101/2022.01.28.22270022 — Posted: 2022-01-29
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 - January 2022
Stefanelli, P., Trentini, F., Petrone, D., Mammone, A., Ambrosio, L., Manica, M., Guzzetta, G., D Andrea, V., Marziano, V., Zardini, A., Molina Grane, C., Ajelli, M., Di Martino, A., Riccardo, F., Bella, A., Sane Schepisi, M., Maraglino, F., Poletti, P., Palamara, A. T., Brusaferro, S., Rezza, G., Pezzotti, P., Merler, S.
10.1101/2022.01.27.22269949 — Posted: 2022-01-29
A Machine Learning Approach to Differentiate Between COVID-19 and Influenza Infection Using Synthetic Infection and Immune Response Data
Farhang-Sardroodi, S., Ghaemi, M., Craig, M., Ooi, H. K., Heffernan, J. M.
10.1101/2022.01.27.22269978 — Posted: 2022-01-29
Hybrid immunity from SARS-CoV-2 delta variant surge induced low to undetectable levels of neutralizing antibodies against Omicron variant
Singh, J., Shaman, H., Singh, B., Anantharaj, A., Pargai, K., Chattopadhyay, P., Devi, P., Maurya, R., Mishra, P., Kahlon, N., Pandey, R., Pandey, A. K., Medigeshi, G. R.
10.1101/2022.01.28.22269990 — Posted: 2022-01-29
Performance of Various Lateral Flow SARS-CoV-2 Antigen Self Testing Methods in Healthcare Workers: a Multicenter Study.
Zwart, V. F., van der Moeren, N., Stohr, J. J. J. M., Feltkamp, M. C. W., Bentvelsen, R. G., Diederen, B. M. W., de Laat, A. C., Mascini, E. M., Schilders, I. G. P., Vlassak, H. T. M., Wertheim, H. F. L., Murk, J.-L. A. N., Kluytmans, J. A. J. W., van den Bijllaardt, W.
10.1101/2022.01.28.22269783 — Posted: 2022-01-29
Calprotectin and inflammation-associated serum biomarkers determine critical illness in COVID-19
Kassianides, G., Siampanos, A., Poulakou, G., Adamis, G., Rapti, A., MIlionis, H., Dalekos, G. N., Petrakis, V., Sympardi, S., Metallidis, S., Alexiou, Z., Gkavogianni, T., Giamarellos-Bourboulis, E., Theoharides, T. C.
10.1101/2022.01.28.22270001 — Posted: 2022-01-29
Agility and sustainability: A qualitative evaluation of COVID-19 Non-pharmaceutical Interventions (NPIs) in the UK logistics sector
Wei, H., Daniels, S. A., Whitfield, C. A., Han, Y., Denning, D. W., Hall, I., Regan, M., Verma, A., van Tongeren, M. J.
10.1101/2022.01.28.22270013 — Posted: 2022-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).